Consistent with a previous report in colorectal cancer lines [35], we observed a marked increase in phosphorylated STAT3 after MEK1/2 inhibition in breast cancer lines, suggesting an acute rewiring of compensatory pathway upon MEK1/2 inhibition (Fig. 1c). This evidence concerns the gene STAT3 and breast carcinoma.